BridgeBio Pharma, Inc. (BBIO)
68.56
+0.44
(+0.65%)
USD |
NASDAQ |
Oct 23, 16:00
68.53
-0.03
(-0.04%)
After-Hours: 20:00
BridgeBio Pharma Total Return Level : 68.56 for Oct. 23, 2026
Total Return Level Chart
Historical Total Return Level Data
| Date | Value |
|---|---|
| October 23, 2026 | 68.56 |
| October 22, 2026 | 68.12 |
| October 21, 2026 | 67.74 |
| October 20, 2026 | 67.55 |
| October 19, 2026 | 67.94 |
| October 16, 2026 | 66.39 |
| October 15, 2026 | 67.13 |
| October 14, 2026 | 64.94 |
| October 13, 2026 | 63.30 |
| October 12, 2026 | 65.75 |
| October 09, 2026 | 65.35 |
| October 08, 2026 | 65.04 |
| October 07, 2026 | 66.50 |
| October 06, 2026 | 66.96 |
| October 05, 2026 | 66.14 |
| October 02, 2026 | 67.25 |
| October 01, 2026 | 66.91 |
| September 30, 2026 | 65.80 |
| September 29, 2026 | 65.97 |
| September 28, 2026 | 66.61 |
| September 25, 2026 | 65.57 |
| September 24, 2026 | 66.28 |
| September 23, 2026 | 65.71 |
| September 22, 2026 | 69.23 |
| September 21, 2026 | 66.58 |
| Date | Value |
|---|---|
| September 18, 2026 | 66.61 |
| September 17, 2026 | 67.31 |
| September 16, 2026 | 68.30 |
| September 15, 2026 | 68.39 |
| September 14, 2026 | 72.38 |
| September 11, 2026 | 72.44 |
| September 10, 2026 | 72.50 |
| September 09, 2026 | 76.08 |
| September 08, 2026 | 74.76 |
| September 04, 2026 | 74.84 |
| September 03, 2026 | 75.41 |
| September 02, 2026 | 76.50 |
| September 01, 2026 | 76.57 |
| August 31, 2026 | 76.59 |
| August 28, 2026 | 76.60 |
| August 27, 2026 | 78.68 |
| August 26, 2026 | 79.37 |
| August 25, 2026 | 80.40 |
| August 24, 2026 | 81.07 |
| August 21, 2026 | 81.50 |
| August 20, 2026 | 82.94 |
| August 19, 2026 | 83.95 |
| August 18, 2026 | 82.98 |
| August 17, 2026 | 79.89 |
| August 14, 2026 | 79.86 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Alnylam Pharmaceuticals, Inc. | 224.03 |
| Pfizer Inc. | 100.45 |
| Ionis Pharmaceuticals, Inc. | 42.93 |
| Cytokinetics, Inc. | 61.23 |
| Vertex Pharmaceuticals, Inc. | 523.93 |